Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T04:00:24.580Z Has data issue: false hasContentIssue false
  • English
  • Français

Una revisión sistemática de la eficacia y la seguridad de los antipsicóticos de segunda generación en el tratamiento de la manía

Published online by Cambridge University Press:  12 May 2020

R. M. Jones ,
C. Thompson  and
I. Bitter
R. M. Jones
Affiliation:
Grupo de Salud Mental, Universidad de Southampton, Southampton, Reino Unido
C. Thompson
Affiliation:
Grupo de Salud Mental, Universidad de Southampton, Southampton, Reino Unido
I. Bitter
Affiliation:
Operaciones Regionales E. Lilly, Viena, Austria Departamento de Psiquiatría y Psicoterapia, Universidad Semmelweis, Budapest, Hungría
Get access

Resumen

Los agentes antipsicóticos de segunda generación se utilizan cada vez más en el tratamiento de la manía aguda. Se realizó una revisión sistemática de la eficacia y la seguridad de estos agentes, tanto en monoterapia como en combinación con estabilizadores del estado de ánimo, para establecer los datos para su uso. Los ensayos controlados distribuidos al azar (ECDA) se valoraron críticamente con más detalle que los estudios que presentaban niveles más bajos de datos, como los informes clínicos, las series clínicas y los estudios de seguimiento al descubierto. Encontramos 11 ECDA que informaban sobre pacientes tratados con antipsicóticos de segunda generación para la manía bipolar aguda, tres de los cuales incluían distribución al azar entre el antipsicótico de segunda generación y el placebo, y ocho entre un estabilizador del estado de ánimo combinado con el antipsicótico de segunda generación o el placebo. Se presentan también datos de ensayos no distribuidos al azar.

Keywords

ManíaTrastorno bipolarSegunda generaciónAntipsicóticoEficaciaSeguridad
Type
Revisión
Information
European Psychiatry (Ed. Española) , Volume 13 , Issue 5 , June 2006 , pp. 217 - 226
Copyright
Copyright © European Psychiatric Association 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aubry, JMSimon, AEBertschy, G. Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reportad cases. J Clin Psychiatry 2000;61(9):649–55.CrossRefGoogle ScholarPubMed
Baker, RWMilton, DRStauffer, VLGelenberg, ATohen, M. Placebo-controlled triais do not find association of olanzapine with exacerbation of bipolar mania. J Affect Disord 2003;73(1-2):147–53.CrossRefGoogle Scholar
Baldassano, CFBallas, CDatto, SMKim, DLittman, LO'Reardon, J, et al.Ziprasidone-associated mania: a case series and review of the mechanism. Bipolar Disord 2003;5(l):72–5.CrossRefGoogle ScholarPubMed
Barkin, JSPals, VM Jr.Gaffney, MF. Induction of mania by risperidone resistant to mood stabilizers. J Clin Psychopharmacol 1997; 17(l):57–8.Google ScholarPubMed
Bech, PBolwig, TKramp, PRafaelsen, O. Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand 1979; 59:420–30.CrossRefGoogle ScholarPubMed
Benazzi, F. Olanzapine-induced psychotic mania in bipolar schizoaffective disorder. Can J Psychiatry 1999;44(6):607–8.Google ScholarPubMed
Berk, MIchim, LBrook, S. Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol 1999; 14(6):339–43.CrossRefGoogle ScholarPubMed
Calabrese, JRKimmel, SEWoyshville, MJRapport, DJFaust, CJThompson, PA, et al.Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153(6):759–64.Google ScholarPubMed
Chang, KDKetter, TA. Mood stabilizer augmentation with olanzapine in acutely manic children. J Child Adoles. Psychopharmacol 2000;10(l):45–9.CrossRefGoogle ScholarPubMed
Chanpattana, W. Combined ECT and clozapine in treatment-resistant mania. J ECT 2000;16(2):204–7.CrossRefGoogle ScholarPubMed
Cookson, J. Use of antipsychodc drugs and lithium in mania. Br J Psychiatry 2001;178(Suppl 41):S148–56.CrossRefGoogle ScholarPubMed
Davis, RRisch, SC. Ziprasidone induction of hypomania in depression?. Am J Psychiatry 2002;159(4):673–4.CrossRefGoogle ScholarPubMed
Delbello, MPSchwiers, MLRosenberg, HLStrakowski, SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002;41 (10): 1216–23.CrossRefGoogle ScholarPubMed
Diaz, SF. Mania associated with risperidone use. J Clin Psychiatry 1996;57(l):41–2.Google ScholarPubMed
Dennehy, EBDoyle, KSuppes, T. The efficacy of olanzapine monotherapy for acute hypomania or mania in an outpatient setting. Int Clin Psychopharmacol 2003; 18(3): 143–5.Google ScholarPubMed
Dunayevich, EStrakowski, SM. Quetiapine for treatment-resistant mania. Am J Psychiatry 2000; 157(8): 1341.CrossRefGoogle ScholarPubMed
Frazier, JABiederman, JTohen, MFeldman, PDJacobs, TGToma, V, et al.A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 2001; 11(3):239–50.CrossRefGoogle ScholarPubMed
Frazier, JAMeyer, MCBiederman, JWozniak, JWilens, TESpencer, TJ, et al.Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry 1999;38(8):960–5.CrossRefGoogle ScholarPubMed
Frye, MAKetter, TAAltshuler, LLDenicoff, KDunn, RTKimbrell, TA, et al.Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 1998;48(2-3):91–104.CrossRefGoogle ScholarPubMed
Ghaemi, SNKatzow, JJ. The use of quetiapine for treatment-resistant bipolar disorder: a case series. Ann Clin Psychiatry 1999; 11(3): 137–40.CrossRefGoogle ScholarPubMed
Ghaemi, SNSachs, GSBaldassano, CFTraman, CJ. Acute treatment of bipolar disorder with adjunctive risperidone in outpatients. Can J Psychiatry 1997;42(2): 196–9.CrossRefGoogle ScholarPubMed
González-Pinto, ALalaguna, BMosquera, FPerezde Heredia, JLGutierrez, MEzcurra, J, et al.Use of olanzapine in dysphoric mania. J Affect Disord 2001;66(2-3):247–53.CrossRefGoogle ScholarPubMed
Goodnick, PJ. Risperidone treatment of refractory acute mania. J Clin Psychiatry 1995;56(9):431–2.Google ScholarPubMed
Green, AITohen, MPatel, JKBanov, MDuRand, CBerman, I, et al.Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry 2000;157(6):982–6.CrossRefGoogle ScholarPubMed
Guezelcan, Y. Risperidone may induce mania. Psychopharmacolog (Berl) 2000; 162 (June).Google Scholar
Henry, CDemotes-Mainard, J. Olanzapine-induced mania in bipolar disorders. J Psychiatry Neurosci 2002;27(3):200-l.Google ScholarPubMed
John, VRapp, MPies, R. Aggression, agitation, and mania with olanzapine. Can J Psychiatry 1998;43(10): 1054.Google ScholarPubMed
Jonkers, FDe Haan, L. Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder. Psychopharmacology (Berl) 2002; 162(1): 87–8.CrossRefGoogle Scholar
Keck, PE Jr.Versiani, MPotkin, SWest, SAGiller, EIce, K. Ziprasidone in the treatment of acute bipolar mania: a 3-week, placebo-controlled, double-blind, randomized trial. Am J Psychiatry 2003; 160(4):741–8.CrossRefGoogle Scholar
Kupfer, DSartorius, N. The usefulness and use of second-generation antipsychotic medications. Review of evidence and recommendations by a Task Forte of the World Psychiatric Association. Curr Opin Psycbiatry 15(Suppl 1):S3–S5.Google Scholar
London, JA. Mania associated with olanzapine. J Am Acad Child Adolesc Psychiatry 1998;37(2): 135–6.CrossRefGoogle ScholarPubMed
Lu, BYLundgren, REscalona, PRRoberts, BB. A case of ziprasidone- induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics. J Clid Psychiatry 2002;63(12): 1185–6.CrossRefGoogle ScholarPubMed
Lykouras, LGoumellis, RAngelopoulos, E. Manic symptoms induced by olanzapine. Eur Neuropsychopharmacol 2001; 11(2):97–8.CrossRefGoogle ScholarPubMed
Masi, GMucci, MMillepiedi, S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol 2002;12(2): 93–9.CrossRefGoogle ScholarPubMed
Meehan, KZhang, FDavid, STohen, MJanicak, PSmall, J, et al.A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. J Clin Psychopharmacol 2001 ;21(4)389–97.CrossRefGoogle ScholarPubMed
McElroy, SLFrye, MDenicoff, KAltshuler, LNolen, WKupka, R, et al.Olanzapine in treatment-resistant bipolar disorder. J Affect Disord 1998;49(2): 119–22.CrossRefGoogle ScholarPubMed
Monreal, JAStaner, L. Actas Esp Psiquiatr 2001 ;29(5):349–50 [Mania, parkinson disease and risperidone. Case report].Google Scholar
Nolan, BPSchulte, JJ Jr.. Mania associated with initiation of ziprasidone. J Clin Psychiatry 2003;64(3):336.CrossRefGoogle ScholarPubMed
Namjoshi, MARajamanuar, GJacobs, TSanger, TMRisser, RTohen, MF, et al.Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial. J Affect Disord 2002;69(1-3): 109–18.CrossRefGoogle ScholarPubMed
Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159(4 Suppl):1–50.Google Scholar
Pozo, PAlcantara, AG. Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment. J Psychiatry Neurosci 1998;23(5):309–10.Google Scholar
Sachs, GSGrossman, FGhaemi, SNOkamoto, ABowden, CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002;159(7): 1146–54.CrossRefGoogle ScholarPubMed
Sachs, GSPrintz, DJKahn, DACarpenter, DDocherty, JP. The Expert Consensus Guideline Series: medication treatment of bipola disorder 2000. Postgrad Med 2002;Spec No: 1–104.Google Scholar
Sajatovic, MDiGiovanui, SKBastani, BHattab, HRamirez, LF. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania. Psychopharmacol Bull 1996;32(1):55–61.Google ScholarPubMed
Segal, JBerk, MBrook, S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol 1998;21(3):176–80.Google ScholarPubMed
Sharma, VPistor, L. Treatment of bipolar mixed State with olanzapine. J Psychiatry Neurosci 1999;24(l):40–4.Google ScholarPubMed
Shi, LNamjoshi, MAZhang, FGandhi, GEdgell, ETTohen, M, et al.Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17(5):227–37.CrossRefGoogle ScholarPubMed
Scbnierow, BJGraeber, DA. Manic symptoms associated with initiation of risperidone. Am J Psychiatry 1996; 153(9): 1235–6.Google Scholar
Soutullo, CASorter, MTFoster, KDMcElroy, SLKeck, PE. Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J Affec Disord 1999;53(3):279–83.CrossRefGoogle ScholarPubMed
Spitzer, REndicott, J. Schedule for affective disorders and schizophrenia: change version. 3rd ed. New York: Biometrics Research, New York State Psychiatri Institute; 1978.Google Scholar
Suppes, TWebb, APaul, BCarmody, TKraemer, HRush, AJ. Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 1999;156(8):1164–9.Google Scholar
Tohen, MZarate, CA Jr.Centorrino, FHegarty, JLFroeschl, MZarate, SB. Risperidone in the treatment of mania. J Clin Psychiatry 1996;57(6):249–53.Google ScholarPubMed
Tohen, MChengappa, KNSuppes, TZarate, CA Jr.Calabrese, JRBowden, CL, et al.Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry 2002;59(l):62–9.CrossRefGoogle ScholarPubMed
Tohen, MJacobs, TGGrundy, SLMcElroy, SLBanov, MCJanicak, PG, et al.Efficacy of olanzapine in acute bipolar mania: a doubleblind, placebo-controlled study. The Olanzipine HGGW Study Group. Arch Gen Psychiatry 2000;57(9):841–9.CrossRefGoogle Scholar
Tohen, MSanger, TMMcElroy, SLTollefson, GDChengappa, KNDaniel, DG, et al.Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group. Am J Psychiatry 1999;156(5):702–9.Google ScholarPubMed
Vleta, EHerraiz, MParramon, GGoikolea, JMFernandez, ABenabarre, A. Risperidone in the treatment of mania: efficacy and safety results from a large, multicentre, open study in Spain. J Affect Disord 2002;72(1):15–9.Google Scholar
Vieta, EParramon, GPadrell, ENieto, EMartinez-Aran, ACorbella, B, et al.Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002;4(5):335–40.CrossRefGoogle ScholarPubMed
Weisler, RHAheam, EPDavidson, JRWallace, CD. Adjunctive use of olanzapine in mood disorders: five case reports. Ann Clin Psychiatry 1997;9(4):259–62.CrossRefGoogle ScholarPubMed
Yatham, LNGrossman, FAugustyns, IVieta, ERavindran, A. Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial. Br J Psychiatry 2003;182:141–7.CrossRefGoogle ScholarPubMed
Young, RCBiggs, JTZiegler, VEMeyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429–35.CrossRefGoogle ScholarPubMed